Population Impact of Heart Failure and the Most Common Forms of Cancer: A Study of 1 162 309 Hospital Cases in Sweden (1988 to 2004)
暂无分享,去创建一个
Inger Ekman | Anders Odén | Simon Stewart | S. Stewart | A. Rosengren | I. Ekman | A. Odén | Annika Rosengren | Tor Ekman | T. Ekman | S. Stewart
[1] V. Roger,et al. Trends in prevalence and outcome of heart failure with preserved ejection fraction. , 2006, The New England journal of medicine.
[2] S Capewell,et al. Heart failure and the aging population: an increasing burden in the 21st century? , 2003, Heart.
[3] A. Odén,et al. Reducing uncertainty in health-care resource allocation , 2007, British Journal of Cancer.
[4] D. Vanuzzo,et al. Does surveillance impact on cardiovascular prevention? , 2009, European heart journal.
[5] K. Swedberg,et al. Decreasing one-year mortality and hospitalization rates for heart failure in Sweden; Data from the Swedish Hospital Discharge Registry 1988 to 2000. , 2003, European Heart Journal.
[6] F. Neumann,et al. New definition of myocardial infarction: impact on long-term mortality. , 2008, The American journal of medicine.
[7] R Westerling,et al. Comparing Swedish hospital discharge records with death certificates: implications for mortality statistics. , 2000, International journal of epidemiology.
[8] E. Ingelsson,et al. The validity of a diagnosis of heart failure in a hospital discharge register , 2005, European journal of heart failure.
[9] Daniel Levy,et al. Long-term trends in the incidence of and survival with heart failure. , 2002, The New England journal of medicine.
[10] J. McMurray,et al. Trends in hospitalization for heart failure in Scotland, 1990-1996. An epidemic that has reached its peak? , 2001, European heart journal.
[11] Colin Simpson,et al. Long-Term Trends in First Hospitalization for Heart Failure and Subsequent Survival Between 1986 and 2003: A Population Study of 5.1 Million People , 2009, Circulation.
[12] Simon Stewart,et al. Home-Based Intervention in Congestive Heart Failure: Long-Term Implications on Readmission and Survival , 2002, Circulation.
[13] B. Yawn,et al. Trends in heart failure incidence and survival in a community-based population. , 2004, JAMA.
[14] P. Wingo,et al. How does breast cancer mortality compare with that of other cancers and selected cardiovascular diseases at different ages in U.S. women? , 2000, Journal of women's health & gender-based medicine.
[15] Salim Yusuf,et al. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.
[16] B. Spilker,et al. Quality of life and pharmacoeconomics in clinical trials , 1996 .
[17] J. Pater. Quality of life and pharmacoeconomics in clinical trials , 1996 .
[18] Adelaide M. Arruda-Olson,et al. Left ventricular function and heart failure in myocardial infarction: impact of the new definition in the community. , 2008, American heart journal.
[19] J. Pell,et al. Age, sex, and social trends in out-of-hospital cardiac deaths in Scotland 1986–95: a retrospective cohort study , 2001, The Lancet.
[20] L. Pilotto. [Estimation of contribution of changes in coronary care to improving survival, event rates, and coronary heart disease mortality across the WHO MONICA Project populations]. , 2000, Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology.
[21] B. Fagerberg,et al. Feasibility of a nurse-monitored, outpatient-care programme for elderly patients with moderate-to-severe, chronic heart failure. , 1998, European heart journal.
[22] S Capewell,et al. More ‘malignant’ than cancer? Five‐year survival following a first admission for heart failure , 2001, European journal of heart failure.
[23] J. McMurray,et al. Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials. , 2004, Journal of the American College of Cardiology.
[24] D. Grobbee,et al. Angiotensin converting enzyme inhibition and hospitalisation rates for heart failure in the Netherlands, 1980 to 1999: the end of an epidemic? , 2002, Heart.
[25] B. G. Blijenberg,et al. Screening and prostate-cancer mortality in a randomized European study. , 2009, The New England journal of medicine.
[26] Fach,et al. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF) , 1999, The Lancet.
[27] D R Jacobs,et al. Trends in Acute Coronary Heart Disease Mortality, Morbidity, and Medical Care From 1985 Through 1997: The Minnesota Heart Survey , 2001, Circulation.
[28] J. Yee,et al. Accuracy of ct colonography for detection of large adenomas and cancers , 2009 .
[29] B. Gersh. Modelling the decreasing coronary heart disease mortality in Sweden between 1986 and 2002 , 2010 .
[30] Hugo A. Katus,et al. Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. , 2000, European heart journal.
[31] A. Jemal,et al. Cancer mortality in the United States by education level and race. , 2007, Journal of the National Cancer Institute.
[32] M. Hashemzadeh,et al. Trends in the age adjusted mortality from acute ST segment elevation myocardial infarction in the United States (1988-2004) based on race, gender, infarct location and comorbidities. , 2009, The American journal of cardiology.